FDA PERMITS EMERGENCY USE OF COVID-19 DRUG BY ELI LILLY & CO

Highlights

• Bamlanivimab developed by Eli Lilly & Co was granted emergency use authorization (EUA) by the FDA based on trial data which showcased that a one-time infusion of the treatment was successful in reducing the need for hospitalization

• This drug from Eli Lilly & Co is a monoclonal antibody, which is widely used class of biotech drugs and this case, it is manufactured copy of an antibody which is....